Liothyronine Sodium Tablets, USP are a thyroid hormone drug indicated:

  • As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.
  • As pituitary thyroid-stimulating hormone (TSH) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s) and multinodular goiter.
  • As diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.
Liothyronine Sodium Tablets, USP
  • Compare to
    Cytomel®*
*Cytomel® is a registered trademark of Pfizer, Inc.

Liothyronine Sodium Tablets, USP (5 mcg)

  • Package size
    90 ct
  • Rating
    AB
  • Strength
    5 mcg
  • NDC Code
    42794-0018-12
Liothyronine Sodium Tablets, USP (5 mcg)

Liothyronine Sodium Tablets, USP (25 mcg)

  • Package size
    90 ct
  • Rating
    AB
  • Strength
    25 mcg
  • NDC Code
    42794-0019-12
Liothyronine Sodium Tablets, USP (25 mcg)

Liothyronine Sodium Tablets, USP (50 mcg)

  • Package size
    90 ct
  • Rating
    AB
  • Strength
    50 mcg
  • NDC Code
    42794-0020-12
Liothyronine Sodium Tablets, USP (50 mcg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.